Worldwide Endobarrier Registry

In view of ABCD’s research interest in Endobarrier as a treatment for diabetes and obesity, we have used the technology developed for ABCD audits to create a worldwide Endobarrier registry. Over 3000 patients have received Endobarrier treatment worldwide and the aim is to collect on the worldwide registry as much of the data on these patients as possible.  At the European Association for the Study of Diabetes (EASD) annual meeting in Barcelona September 2019, data was presented on the on 871 patients from 28 centres in 8 countries: Australia, Austria, Brazil, Czech Republic, Germany, Israel, Netherlands and United Kingdom.  For more information about the Endobarrier worldwide registry, including registering to join it and accessing the registry online tool, please visit the following page: